Active	Status	Sponsor type	Region	Phase	Filter
11 Active 4 Inactive 15 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   - « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   Show only changed items Enrollment:

Advanced Filters

8 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Wei, Li
NCT06747455: BCG for Therapeutic Use Phase Ⅲ Clinical Trial	Recruiting	3	438	RoW	BCG for Therapeutic Use, BCG for Therapeutic Use ( BI SAI JI )	Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.	BCG	10/28	12/28
NCT05442346: Safety and Efficacy Evaluation of γ-globin Reactivated Autologous Hematopoietic Stem Cells	Suspended	N/A	5	RoW	γ-globin reactivated autologous hematopoietic stem cells	Bioray Laboratories, First Affiliated Hospital of Guangxi Medical University	Thalassemia Major	09/24	11/24
SPEED, NCT06862206: This is a Non-interventional, Study to Assess Demographic Characteristics and Patient Reported Outcomes in China Patients With SEA Treated With Benralizumab	Not yet recruiting	N/A	1000	RoW	benralizumab	AstraZeneca	Chronic Obstructive Pulmonary Disease	01/26	01/26
Liu, Zuguo
NCT04633213: A Study Evaluating HBM9036 Efficacy and Safety on Moderate to Severe Dry Eye	Recruiting	3	674	RoW	HBM9036 0.25% Ophthalmic Solution, Placebo	Harbour BioMed (Guangzhou) Co. Ltd.	Dry Eye	12/22	04/23
NCT05629390: Trial to Evaluate the Efficacy and Safety of TP-03, LIBRA Study	Completed	3	163	RoW	Lotilaner, TP-03, S-Misoxam, Vehicle Control	LianBio LLC	Blepharitis	09/23	04/24
NCT06717152: Efficacy and Safety of SJP-0132 Eye Drops in Chinese Patients With Dry Eye Disease	Recruiting	3	400	RoW	SJP-0132, Placebo	Senju Pharmaceutical Science & Technology (Beijing) Co., Ltd., Senju Pharmaceutical Co., Ltd.	Dry Eye	07/25	08/25
ZKO-CSP-CSA-302, NCT06766357: A Study of the Efficacy and Safety of Cyclosporin Ophthalmic Gel in Subjects with Moderate to Severe Dry Eye Disease	Not yet recruiting	3	360	RoW	Cyclosporine ophthalmic gel, Cyclosporine, Cyclosporine ophthalmic gel vehicle, Vehicle	Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.	Moderate to Severe Dry Eye	02/26	06/26
NCT06133166: A Study for the Treatment of Dry Eye in Postmenopausal Women	Recruiting	2	240	RoW	EG017 ointment, EG017 ointment placebo	Changchun GeneScience Pharmaceutical Co., Ltd.	Postmenopausal Women With DED	05/24	08/24

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Wei, Li
NCT06747455: BCG for Therapeutic Use Phase Ⅲ Clinical Trial	Recruiting	3	438	RoW	BCG for Therapeutic Use, BCG for Therapeutic Use ( BI SAI JI )	Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.	BCG	10/28	12/28
NCT05442346: Safety and Efficacy Evaluation of γ-globin Reactivated Autologous Hematopoietic Stem Cells	Suspended	N/A	5	RoW	γ-globin reactivated autologous hematopoietic stem cells	Bioray Laboratories, First Affiliated Hospital of Guangxi Medical University	Thalassemia Major	09/24	11/24
SPEED, NCT06862206: This is a Non-interventional, Study to Assess Demographic Characteristics and Patient Reported Outcomes in China Patients With SEA Treated With Benralizumab	Not yet recruiting	N/A	1000	RoW	benralizumab	AstraZeneca	Chronic Obstructive Pulmonary Disease	01/26	01/26
Liu, Zuguo
NCT04633213: A Study Evaluating HBM9036 Efficacy and Safety on Moderate to Severe Dry Eye	Recruiting	3	674	RoW	HBM9036 0.25% Ophthalmic Solution, Placebo	Harbour BioMed (Guangzhou) Co. Ltd.	Dry Eye	12/22	04/23
NCT05629390: Trial to Evaluate the Efficacy and Safety of TP-03, LIBRA Study	Completed	3	163	RoW	Lotilaner, TP-03, S-Misoxam, Vehicle Control	LianBio LLC	Blepharitis	09/23	04/24
NCT06717152: Efficacy and Safety of SJP-0132 Eye Drops in Chinese Patients With Dry Eye Disease	Recruiting	3	400	RoW	SJP-0132, Placebo	Senju Pharmaceutical Science & Technology (Beijing) Co., Ltd., Senju Pharmaceutical Co., Ltd.	Dry Eye	07/25	08/25
ZKO-CSP-CSA-302, NCT06766357: A Study of the Efficacy and Safety of Cyclosporin Ophthalmic Gel in Subjects with Moderate to Severe Dry Eye Disease	Not yet recruiting	3	360	RoW	Cyclosporine ophthalmic gel, Cyclosporine, Cyclosporine ophthalmic gel vehicle, Vehicle	Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.	Moderate to Severe Dry Eye	02/26	06/26
NCT06133166: A Study for the Treatment of Dry Eye in Postmenopausal Women	Recruiting	2	240	RoW	EG017 ointment, EG017 ointment placebo	Changchun GeneScience Pharmaceutical Co., Ltd.	Postmenopausal Women With DED	05/24	08/24